Capricor Therapeutics Inc (CAPR)
4.66
-0.13
(-2.71%)
USD |
NASDAQ |
Jun 25, 16:00
4.64
-0.02
(-0.43%)
After-Hours: 20:00
Capricor Therapeutics Revenue (Annual): 25.18M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 25.18M |
| December 31, 2022 | 2.552M |
| December 31, 2021 | 0.2449M |
| December 31, 2020 | 0.3103M |
| December 31, 2019 | 1.005M |
| December 31, 2018 | 1.671M |
| December 31, 2017 | 2.666M |
| December 31, 2016 | 3.190M |
| December 31, 2015 | 3.776M |
| December 31, 2014 | 4.167M |
| December 31, 2013 |
| Date | Value |
|---|---|
| December 31, 2012 | |
| December 31, 2011 | 1.354M |
| December 31, 2010 | |
| December 31, 2009 | |
| December 31, 2008 | |
| December 31, 2007 | 0.1014M |
| December 31, 2006 | 0.3808M |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | 0.0022M |
| December 31, 2002 | 0.0115M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.2449M
Minimum
2021
25.18M
Maximum
2023
5.858M
Average
1.005M
Median
2019
Revenue (Annual) Benchmarks
| Cutera Inc | 212.37M |
| Inovio Pharmaceuticals Inc | 0.832M |
| Stereotaxis Inc | 26.77M |
| Vaxart Inc | 7.379M |
| Allogene Therapeutics Inc | 0.095M |